Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-321
Closed -$52K 86
2022
Q2
$52K Hold
321
0.05% 77
2022
Q1
$120K Sell
321
-12
-4% -$4.05K 0.09% 79
2021
Q4
$131K Hold
333
0.09% 81
2021
Q3
$250K Hold
333
0.19% 70
2021
Q2
$347K Hold
333
0.25% 67
2021
Q1
$501K Buy
+333
New +$484K 0.41% 54

Other funds holding YCBD

swisspartners's YCBD Position: Q3 2022 in Review

swisspartners sold out of cbdMD (YCBD) in Q3 2022, closing a stake of 321 shares — an estimated $52K sold.

swisspartners first reported a position in YCBD in Q1 2021 and held it in 6 quarters. The position peaked at $501K in Q1 2021. 46 funds tracked by Wall St. Rank hold YCBD as of Q3 2022.

  • swisspartners reported no remaining cbdMD position as of Q3 2022 after selling out during the quarter.
  • swisspartners sold 321 cbdMD shares in Q3 2022, an estimated $52K.
  • swisspartners first reported a position in cbdMD in Q1 2021 and held it in 6 quarters.
  • swisspartners's cbdMD position peaked at $501K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held cbdMD as of Q3 2022.

Based on swisspartners's 13F filing for Q3 2022, filed 1 Nov 2022.